Charles Sanders, a former chief executive officer of Glaxo, is the new chairman of the board at pharmaceutical development firm Icagen.
Sanders replaces Jefferson Leighton, who had served as chairman since 1992. Leighton retired, citing family reasons. Sanders joined the board of Icagen in 1997.
Icagen: www.icagen.com
